ZA9810637B - Formulations comprising dissolved paroxetine. - Google Patents

Formulations comprising dissolved paroxetine.

Info

Publication number: ZA9810637B
Authority: ZA; South Africa
Prior art keywords: formulations; paroxetine; dissolved; dissolved paroxetine
Prior art date: 1997-11-21

Application number

ZA9810637A

Other languages

English (en)

Inventor

Graham Stanley Leonard

Ahmad Ghazawi

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-21

Filing date

1998-11-20

Publication date

2000-05-22

1998-11-20 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-05-22 Publication of ZA9810637B publication Critical patent/ZA9810637B/xx

Links

AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229960002296 paroxetine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

ZA9810637A 1997-11-21 1998-11-20 Formulations comprising dissolved paroxetine. ZA9810637B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9724544.3A GB9724544D0 (en)	1997-11-21	1997-11-21	Novel Formulation

Publications (1)

Publication Number	Publication Date
ZA9810637B true ZA9810637B (en)	2000-05-22

Family

ID=10822374

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9810637A ZA9810637B (en)	1997-11-21	1998-11-20	Formulations comprising dissolved paroxetine.

Country Status (24)

Country	Link
EP (1)	EP1033986A1 (fr)
JP (1)	JP2001523718A (fr)
KR (1)	KR20010032320A (fr)
CN (1)	CN1279608A (fr)
AP (1)	AP2000001821A0 (fr)
AR (1)	AR015485A1 (fr)
AU (1)	AU1168099A (fr)
BG (1)	BG104527A (fr)
BR (1)	BR9814220A (fr)
CO (1)	CO4970832A1 (fr)
DZ (1)	DZ2658A1 (fr)
EA (1)	EA200000552A1 (fr)
GB (1)	GB9724544D0 (fr)
HU (1)	HUP0100580A3 (fr)
IL (1)	IL136106A0 (fr)
MA (1)	MA24704A1 (fr)
NO (1)	NO20002590L (fr)
OA (1)	OA11385A (fr)
PE (1)	PE20000381A1 (fr)
PL (1)	PL340555A1 (fr)
SK (1)	SK7342000A3 (fr)
TR (1)	TR200001423T2 (fr)
WO (1)	WO1999026625A1 (fr)
ZA (1)	ZA9810637B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9810180D0 (en) *	1998-05-13	1998-07-08	Smithkline Beecham Plc	Novel formulation
ATE311883T1 (de)	1999-03-12	2005-12-15	Aesica Pharmaceuticals Ltd	Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
CA2341984A1 (fr)	1999-07-01	2001-01-11	Italfarmaco S.P.A.	Complexes de paroxetine, avec des cyclodextrines et des derives de la cyclodextrine
DE19930454A1 (de) *	1999-07-02	2001-01-04	Knoll Ag	Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en)	2001-02-16	2004-04-13	Andrx Corporation	Serotonin reuptake inhibitor formulations
ATE374602T1 (de) *	2001-12-21	2007-10-15	Supernus Pharmaceuticals Inc	Orale kapselformulierung mit verbesserter physikalischer stabilität
SE0200475D0 (sv) *	2002-02-15	2002-02-15	Ltp Lipid Technologies Provide	Oral farmaceutisk beredning
WO2006119779A2 (fr) *	2005-05-10	2006-11-16	Lifecycle Pharma A/S	Composition pharmaceutique comprenant un antagoniste de l'aldosterone
US20120322752A1 (en) *	2009-12-08	2012-12-20	Sung Kyun Lee	SOLID DISPERSIONS CONTAINING 20-O-beta-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL
GB201020032D0 (en) *	2010-11-25	2011-01-12	Sigmoid Pharma Ltd	Composition
CN103961333B (zh) *	2014-05-07	2020-02-21	浙江华海药业股份有限公司	甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996031197A1 (fr) *	1995-04-03	1996-10-10	Abbott Laboratories	Melanges homogenes de medicaments fondant a basse temperature et d'additifs, destines a une liberation lente
JP2001508460A (ja) *	1997-01-15	2001-06-26	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	パロキセチン組成物

1997
- 1997-11-21 GB GBGB9724544.3A patent/GB9724544D0/en not_active Ceased
1998
- 1998-11-18 IL IL13610698A patent/IL136106A0/xx unknown
- 1998-11-18 KR KR1020007005532A patent/KR20010032320A/ko not_active Withdrawn
- 1998-11-18 PL PL98340555A patent/PL340555A1/xx unknown
- 1998-11-18 EA EA200000552A patent/EA200000552A1/ru unknown
- 1998-11-18 EP EP98954631A patent/EP1033986A1/fr not_active Withdrawn
- 1998-11-18 BR BR9814220-8A patent/BR9814220A/pt not_active Application Discontinuation
- 1998-11-18 AP APAP/P/2000/001821A patent/AP2000001821A0/en unknown
- 1998-11-18 TR TR2000/01423T patent/TR200001423T2/xx unknown
- 1998-11-18 DZ DZ980268A patent/DZ2658A1/fr active
- 1998-11-18 HU HU0100580A patent/HUP0100580A3/hu unknown
- 1998-11-18 CN CN98811404A patent/CN1279608A/zh active Pending
- 1998-11-18 AU AU11680/99A patent/AU1168099A/en not_active Abandoned
- 1998-11-18 SK SK734-2000A patent/SK7342000A3/sk unknown
- 1998-11-18 PE PE1998001126A patent/PE20000381A1/es not_active Application Discontinuation
- 1998-11-18 WO PCT/GB1998/003471 patent/WO1999026625A1/fr not_active Ceased
- 1998-11-18 JP JP2000521827A patent/JP2001523718A/ja active Pending
- 1998-11-19 AR ARP980105880A patent/AR015485A1/es unknown
- 1998-11-19 MA MA25357A patent/MA24704A1/fr unknown
- 1998-11-20 CO CO98068459A patent/CO4970832A1/es unknown
- 1998-11-20 ZA ZA9810637A patent/ZA9810637B/xx unknown
2000
- 2000-05-19 OA OA1200000153A patent/OA11385A/en unknown
- 2000-05-19 NO NO20002590A patent/NO20002590L/no not_active Application Discontinuation
- 2000-06-13 BG BG104527A patent/BG104527A/xx unknown

Also Published As

Publication number	Publication date
CO4970832A1 (es)	2000-11-07
GB9724544D0 (en)	1998-01-21
HUP0100580A2 (hu)	2002-04-29
BG104527A (en)	2001-04-30
JP2001523718A (ja)	2001-11-27
NO20002590L (no)	2000-07-19
WO1999026625A1 (fr)	1999-06-03
KR20010032320A (ko)	2001-04-16
AU1168099A (en)	1999-06-15
DZ2658A1 (fr)	2003-03-22
IL136106A0 (en)	2001-05-20
CN1279608A (zh)	2001-01-10
MA24704A1 (fr)	1999-07-01
SK7342000A3 (en)	2000-12-11
EP1033986A1 (fr)	2000-09-13
BR9814220A (pt)	2001-12-26
NO20002590D0 (no)	2000-05-19
PE20000381A1 (es)	2000-05-07
OA11385A (en)	2004-01-27
TR200001423T2 (tr)	2000-10-23
PL340555A1 (en)	2001-02-12
EA200000552A1 (ru)	2000-10-30
AR015485A1 (es)	2001-05-02
HUP0100580A3 (en)	2002-05-28
AP2000001821A0 (en)	2000-06-30

Publication	Publication Date	Title
ZA993338B (en)	2000-11-14	Pharmaceutical formulations.
ZA982253B (en)	1999-09-17	Therapeutic compositions.
ZA993938B (en)	2000-12-14	Ziprasidone formulations.
ZA984849B (en)	1999-12-06	Compositions.
GB9715751D0 (en)	1997-10-01	Formulations
ZA9811848B (en)	2000-06-26	Vaccine.
ZA984969B (en)	1999-12-09	Vaccine.
ZA988789B (en)	2000-03-29	Vaccine.
GB9804013D0 (en)	1998-04-22	Formulations
ZA976777B (en)	1998-02-11	Anthelmintic formulations.
MXPA02001088A (es)	2003-09-22	2-pirazolin-5-onas..
ZA981029B (en)	1999-08-10	Pharmaceutical agents.
MXPA01012478A (es)	2003-10-14	Formulaciones farmaceuticas mejoradas.
ZA989680B (en)	1999-07-23	Pharmaceutical composition.
AU134029S (en)	1998-06-15	Tillage point
IL136106A0 (en)	2001-05-20	Formulations comprising dissolved paroxetine
AU134028S (en)	1998-06-15	Tillage point
ZA987392B (en)	2000-02-17	Pharmaceutical composition.
ZA200005697B (en)	2001-10-02	Paroxetine compositions.
ZA99890B (en)	2000-08-04	Pharmaceutical compositions.
GB9815002D0 (en)	1998-09-09	Formulations
ZA988206B (en)	2000-03-09	Piperidinylmethyloxazolidinone derivative.
GB9815001D0 (en)	1998-09-09	Formulations
ZA984696B (en)	1999-01-04	Vaccine compositions V.
ZA981739B (en)	1999-09-02	Composition.